Clinical Trial Update: Cardiac Safety of Lansoprazole and Domperidon Combination [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the cardiac safety of a lansoprazole and domperidone combination was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Domperidone (domperidone)
• Lansoprazole (Lansoprazole)
• Lansoprazole and domperidone combination

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: GERD, Cardiac Event | Phase 4 | Status: WITHDRAWN